{"id":2479,"date":"2024-02-07T01:58:58","date_gmt":"2024-02-07T01:58:58","guid":{"rendered":"https:\/\/bukka.phar.kyushu-u.ac.jp\/?post_type=publication&#038;p=2479"},"modified":"2024-05-02T05:06:56","modified_gmt":"2024-05-02T05:06:56","slug":"ethoxyquin-a-lipid-peroxidation-inhibitor-has-protective-effects-against-white-matter-lesions-in-a-mouse-model-of-chronic-cerebral-hypoperfusion","status":"publish","type":"publication","link":"https:\/\/bukka.phar.kyushu-u.ac.jp\/en\/publication\/ethoxyquin-a-lipid-peroxidation-inhibitor-has-protective-effects-against-white-matter-lesions-in-a-mouse-model-of-chronic-cerebral-hypoperfusion\/","title":{"rendered":"Ethoxyquin a Lipid Peroxidation Inhibitor Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion."},"content":{"rendered":"<div class=\"publication_wrap\">\n\t<h3><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38171771\/\" target=\"_blank\">Ethoxyquin a Lipid Peroxidation Inhibitor Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion.<\/a><\/h3>\n\t\n  Abe M, Sou M, Matsuoka Y, Morimoto K, Yamada KI.<br>\n  <em>Biol Pharm Bull. <\/em>\n  47(1):104-111, 2024<\/div>","protected":false},"featured_media":0,"template":"","_links":{"self":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2479"}],"collection":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/types\/publication"}],"version-history":[{"count":2,"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2479\/revisions"}],"predecessor-version":[{"id":2621,"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/publication\/2479\/revisions\/2621"}],"wp:attachment":[{"href":"https:\/\/bukka.phar.kyushu-u.ac.jp\/wp-json\/wp\/v2\/media?parent=2479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}